Overall rank by patents
#24,507
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 27 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients).
The verdict
Imerys holds 11 US patents across 27 technology areas, rank #24,507 of 50,000 tracked assignees.
Imerys Minerals Limited has been granted 11 US utility patents between 2015 and 2022, placing Imerys Minerals Limited at rank #24,507 across all assignees tracked by PlainPatent. This portfolio spans 27 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.1 claims per patent with primary concentration in C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients). As a Foreign Corporation, Imerys Minerals Limited is one of the more focused assignees in the PatentsView dataset. By volume, Imerys sits between ICE Data, Lp (11 patents, rank #24,503) and INDI Molecular, Inc. (11 patents, rank #24,511) - the closest US assignees by grant volume. The composite Innovation Score of 45.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 10 in the 2015–2019 window, a -90% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Imerys Minerals Limited's 20.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 27 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Imerys Minerals Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ICE Data, LP
11 patents
ID TECHNOLOGY LLC
11 patents
IMCYSE SA
11 patents
IMERGY POWER SYSTEMS, INC.
11 patents
IMMODULON THERAPEUTICS LIMITED
11 patents
IMPACT THERAPEUTICS, INC.
11 patents
IMPULSE DOWNHOLE SOLUTIONS LTD.
11 patents
INDI MOLECULAR, INC.
11 patents
IMERYS MINERALS LIMITED
11 patents
What this shows Imerys holds 11 patents at rank #24,507, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Imerys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2018 | 5 | 45.5% |
| 2022 | 1 | 9.1% |
Top 15 of 27 technology areas
Overall rank by patents
#24,507
Across all tracked assignees
45.7 out of 100
How to use this portfolio
Imerys's 11 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.